Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Uncomplicated Childhood Malaria by an Artemisinin Derivative in Combination With Lumefantrine. Efficacy, Safety and Genotyping.

NCT00336375 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT00336375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00336375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Uncomplicated Childhood Malaria by an Artemisinin Derivative in Combination With Lumefantrine. Efficacy, Safety and Genotyping.
Lead sponsor
Karolinska University Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2006
Completion date
July 31, 2006
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria